company background image
CNMD logo

CONMED NYSE:CNMD Rapport sur les actions

Dernier prix

US$72.24

Capitalisation boursière

US$2.2b

7D

-1.6%

1Y

-32.9%

Mise à jour

15 Nov, 2024

Données

Finances de l'entreprise +

CONMED Corporation

NYSE:CNMD Rapport sur les actions

Capitalisation boursière : US$2.2b

CNMD Aperçu des actions

CONMED Corporation, une entreprise de technologie médicale, développe, fabrique et vend des dispositifs chirurgicaux et des équipements connexes pour les procédures chirurgicales dans le monde entier. Plus de détails

CNMD analyse fondamentale
Score flocon de neige
Évaluation5/6
Croissance future1/6
Performances passées4/6
Santé financière3/6
Dividendes3/6

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

US$83.13
FV
13.1% undervalued intrinsic discount
6.79%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
1 day ago author updated this narrative

CONMED Corporation Concurrents

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour CONMED
Historique des cours de bourse
Prix actuel de l'actionUS$72.24
Plus haut sur 52 semainesUS$117.27
Plus bas sur 52 semainesUS$61.05
Bêta1.46
1Variation sur 1 mois10.32%
Variation sur 3 mois7.24%
Variation sur 1 an-32.86%
3Variation sur 3 ans-49.13%
Variation sur 5 ans-36.23%
Évolution depuis l'introduction en bourse3,512.00%

Nouvelles et mises à jour récentes

CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem

Nov 07
CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem

Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Nov 02
Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Recent updates

CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem

Nov 07
CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem

Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Nov 02
Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$71.92?

Oct 01
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$71.92?

Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price

Sep 12
Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

Aug 15
CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price

Jul 17
CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price

AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation

Jun 21

There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

Jun 01
There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Apr 18
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Mar 28
Is CONMED (NYSE:CNMD) Using Too Much Debt?

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

Feb 15
CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Feb 03
US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Jan 08
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

Dec 18
Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Nov 30
CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Oct 28

Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Sep 22
Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Aug 24
Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly

Jul 28

Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

Jun 08
Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

May 17
These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Apr 28
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Mar 10
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

Feb 14
Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M

Feb 02

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Jan 24
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

ConMed: Still Fairly Priced, Turning More Constructive

Dec 09

At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Nov 18
At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Conmed withdraws FY22 guidance on software implementation-related disruption

Nov 15

CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

Oct 11
CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

Rendement pour les actionnaires

CNMDUS Medical EquipmentUS Marché
7D-1.6%-0.4%-0.5%
1Y-32.9%22.2%32.3%

Rendement vs Industrie: CNMD a sous-performé le secteur US Medical Equipment qui a rapporté 22.2 % au cours de l'année écoulée.

Rendement vs marché: CNMD a sous-performé le marché US qui a rapporté 32.3 % au cours de l'année écoulée.

Volatilité des prix

Is CNMD's price volatile compared to industry and market?
CNMD volatility
CNMD Average Weekly Movement5.4%
Medical Equipment Industry Average Movement7.8%
Market Average Movement6.2%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.0%

Cours de l'action stable: CNMD n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.

Volatilité au fil du temps: La volatilité hebdomadaire de CNMD ( 5% ) est restée stable au cours de l'année écoulée.

À propos de l'entreprise

FondéeSalariésPDGSite web
19704,000Curt Hartmanwww.conmed.com

CONMED Corporation, une entreprise de technologie médicale, développe, fabrique et vend des appareils chirurgicaux et du matériel connexe pour des procédures chirurgicales dans le monde entier. La société propose des produits de chirurgie orthopédique, notamment BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors et Agro Knotless Suture Anchors, qui offrent des solutions cliniques aux chirurgiens orthopédiques pour l'augmentation et la réparation des lésions des tissus mous, ainsi que des produits complémentaires qui permettent aux chirurgiens de pratiquer des opérations de médecine sportive peu invasives. Elle commercialise des produits de chirurgie orthopédique sous les marques Hall, CONMED Linvatec, Concept et Shutt.

CONMED Corporation Résumé des fondamentaux

Comment les bénéfices et les revenus de CONMED se comparent-ils à sa capitalisation boursière ?
CNMD statistiques fondamentales
Capitalisation boursièreUS$2.20b
Bénéfices(TTM)US$131.74m
Recettes(TTM)US$1.29b

16.9x

Ratio P/E

1.7x

Ratio P/S

Le site CNMD est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
CNMD compte de résultat (TTM)
RecettesUS$1.29b
Coût des recettesUS$569.15m
Marge bruteUS$718.96m
Autres dépensesUS$587.22m
Les revenusUS$131.74m

Derniers bénéfices déclarés

Sep 30, 2024

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)4.26
Marge brute55.82%
Marge bénéficiaire nette10.23%
Ratio dettes/capitaux propres100.6%

Quelles ont été les performances à long terme de CNMD?

Voir les performances historiques et les comparaisons

Dividendes

1.1%

Rendement actuel des dividendes

19%

Ratio de distribution